|
STAT5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.021600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.581890E-04 |
| Normal-vs-Stage2 |
5.128400E-01 |
| Normal-vs-Stage3 |
2.366000E-01 |
| Normal-vs-Stage4 |
2.324700E-03 |
| Stage1-vs-Stage2 |
1.755000E-01 |
| Stage1-vs-Stage3 |
1.001990E-04 |
| Stage1-vs-Stage4 |
1.86239999977467E-07 |
| Stage2-vs-Stage3 |
1.678020E-01 |
| Stage2-vs-Stage4 |
1.507950E-02 |
| Stage3-vs-Stage4 |
8.836100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.990160E-01 |
| Normal-vs-AfricanAmerican |
9.317800E-01 |
| Normal-vs-Asian |
2.052400E-01 |
| Caucasian-vs-AfricanAmerican |
4.766000E-01 |
| Caucasian-vs-Asian |
2.283200E-01 |
| AfricanAmerican-vs-Asian |
2.003400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.835600E-01 |
| Normal-vs-Female |
1.654570E-01 |
| Male-vs-Female |
5.250200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.229000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.148470E-02 |
| Normal-vs-Age(61-80Yrs) |
9.501800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.437800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.046770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.744000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.817600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.078100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.188360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.791200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.993120E-04 |
| Normal-vs-Grade 2 |
4.978400E-04 |
| Normal-vs-Grade 3 |
9.173800E-01 |
| Normal-vs-Grade 4 |
1.381250E-04 |
| Grade 1-vs-Grade 2 |
2.982100E-03 |
| Grade 1-vs-Grade 3 |
4.04400000000305E-05 |
| Grade 1-vs-Grade 4 |
8.42530001321506E-09 |
| Grade 2-vs-Grade 3 |
1.461380E-03 |
| Grade 2-vs-Grade 4 |
9.95019999727731E-09 |
| Grade 3-vs-Grade 4 |
7.432400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.60619986597521E-10 |
| Normal-vs-ccB subtype |
5.287800E-02 |
| ccA subtype-vs-ccB subtype |
1.38022926421399E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.824200E-01 |
| Normal-vs-N1 |
1.511020E-01 |
| N0-vs-N1 |
1.170370E-01 |
|
|
